Abstract: A generic domain compute system that is customizable for at least one domain or zone compute in a vehicle having a gateway power and control (GAPAC). The GAPAC has a power supply, a scalable microcontroller, a power management integrated circuit, a set of standardized and scalable external connectors for external inter-connections for Ethernet and car connector, a standard and scalable internal connector for internal inter-connections for power, control and generic busses. At least a first compute extension (COMEX) has a standard and scalable connecter internally connected to the GAPAC. The COMEX has a scalable microcontroller, a power management integrated circuit and a set of standardized and scalable connectors for external inter-connections. The COMEX is supplied with a permanent voltage from the GAPAC power supply. The microcontrollers, external connectors and internal connectors are scaled according to the domain or zone compute application.

Abstract: An enteric-coated oral dosage form comprising an acid labile active pharmaceutical ingredient where the composition is substantially free of monomeric phthalic acid esters and synthetic oils is described herein. Also provided are methods for making and using the enteric-coated oral dosage form. The disclosed pharmaceutical compositions comprise an enteric coating which includes at least one plasticizer, at least one film-forming agent and optionally at least one anti-sticking agent.

Abstract: An enteric-coated oral dosage form comprising an acid labile active pharmaceutical ingredient where the composition is substantially free of monomeric phthalic acid esters and synthetic oils is described herein. Also provided are methods for making and using the enteric-coated oral dosage form. The disclosed pharmaceutical compositions comprise an enteric coating which includes at least one plasticizer, at least one film-forming agent and optionally at least one anti-sticking agent.

Abstract: A generic domain compute system that is customizable for at least one domain or zone compute in a vehicle having a gateway power and control (GAPAC). The GAPAC has a power supply, a scalable microcontroller, a power management integrated circuit, a set of standardized and scalable external connectors for external inter-connections for Ethernet and car connector, a standard and scalable internal connector for internal inter-connections for power, control and generic busses. At least a first compute extension (COMEX) has a standard and scalable connecter internally connected to the GAPAC. The COMEX has a scalable microcontroller, a power management integrated circuit and a set of standardized and scalable connectors for external inter-connections. The COMEX is supplied with a permanent voltage from the GAPAC power supply. The microcontrollers, external connectors and internal connectors are scaled according to the domain or zone compute application.

Abstract: An enteric-coated oral dosage form comprising an acid labile active pharmaceutical ingredient where the composition is substantially free of monomeric phthalic acid esters and synthetic oils is described herein. Also provided are methods for making and using the enteric-coated oral dosage form. The disclosed pharmaceutical compositions comprise an enteric coating which includes at least one plasticizer, at least one film-forming agent and optionally at least one anti-sticking agent.

Abstract: An enteric-coated oral dosage form comprising an acid labile active pharmaceutical ingredient where the composition is substantially free of monomeric phthalic acid esters and synthetic oils is described herein. Also provided are methods for making and using the enteric-coated oral dosage form. The disclosed pharmaceutical compositions comprise an enteric coating which includes at least one plasticizer, at least one film-forming agent and optionally at least one anti-sticking agent.

Abstract: An enteric-coated oral dosage form comprising an acid labile active pharmaceutical ingredient where the composition is substantially free of monomeric phthalic acid esters and synthetic oils is described herein. Also provided are methods for making and using the enteric-coated oral dosage form. The disclosed pharmaceutical compositions comprise an enteric coating which includes at least one plasticizer, at least one film-forming agent and optionally at least one anti-sticking agent.

Abstract: A device and method for controlling reproduction of an audio signal is provided, wherein the device is operated by means of an energy storage device. The method comprises the steps of deactivating a normal mode and activating an energy saving mode. Power consumption from the energy storage device for reproduction of the audio signal is reduced in the energy saving mode when compared to the normal mode. The method comprises reducing in the energy saving mode, a bass frequency component of a frequency spectrum of the audio signal and outputting the audio signal with reduced bass frequency component. The method further comprises ascertaining a charge state of the energy storage device and controlling the reduction in the bass frequency component based on a decrease in the charge state of the energy storage device.

Abstract: A method and system for generating augmented reality with a display of a vehicle is provided. The method comprises recording an image of an environment of the vehicle in the form of image data, determining a virtual space in three dimensions from the image data, and detecting a real object in the image data. The method further comprises determining a first coordinate range of the real object in the three dimensional virtual space, adding a virtual element to the three dimensional virtual space, and controlling the virtual element in the three dimensional virtual space based on a user input. The method further comprises outputting the environment and the controlled virtual element in combined form in an output image, modifying the output image when the first coordinate range of the real object and a second coordinate range of the controlled virtual element form an intersection area, and displaying the output image.

Abstract: An enteric-coated oral dosage form comprising an acid labile active pharmaceutical ingredient where the composition is substantially free of monomeric phthalic acid esters and synthetic oils is described herein. Also provided are methods for making and using the enteric-coated oral dosage form. The disclosed pharmaceutical compositions comprise an enteric coating which includes at least one plasticizer, at least one film-forming agent and optionally at least one anti-sticking agent.

Abstract: An enteric-coated oral dosage form comprising an acid labile active pharmaceutical ingredient where the composition is substantially free of monomeric phthalic acid esters and synthetic oils is described herein. Also provided are methods for making and using the enteric-coated oral dosage form. The disclosed pharmaceutical compositions comprise an enteric coating which includes at least one plasticizer, at least one film-forming agent and optionally at least one anti-sticking agent.

Abstract: An enteric-coated oral dosage form comprising an acid labile active pharmaceutical ingredient where the composition is substantially free of monomeric phthalic acid esters and synthetic oils is described herein. Also provided are methods for making and using the enteric-coated oral dosage form. The disclosed pharmaceutical compositions comprise an enteric coating which includes at least one plasticizer, at least one film-forming agent and optionally at least one anti-sticking agent.

Abstract: In an arrangement and method for active vibration compensation of an x-ray radiator, a counter-vibration generation unit is arranged within the x-ray radiator to reduce a vibration arising during operation of the x-ray radiator. The counter-vibration generating unit is engaged in an active connection with the x-ray radiator and generates a counter-vibration that is phase-shifted by 180 degrees relative to the operational vibration. Operational vibrations generated by the x-ray radiator can be directly reduced at the point of origin by the application of active counter-vibrations in the immediate proximity of the vibration generator. Additional vibration transmission to other system parts (for example a C-arm) is thereby reduced or prevented.

Abstract: Media content playback includes providing a plurality of media contents; providing for each of the media contents information identifying the respective media content; receiving from a user selection instructions that effect selecting or deselecting of a specific media content; providing context data based on measurements of at least one of absolute time, absolute position and of at least one physical quantity at or in the vicinity of the location where the selected media content is to be reproduced; providing or adapting a user profile that assigns for each specific media content user instructions to the context data provided at the time of receipt of the respective instruction; selecting according to the user profile one of the media contents dependent on the context data at the time of selection; and reproducing the selected media content.

Abstract: An enteric-coated oral dosage form comprising an acid labile active pharmaceutical ingredient where the composition is substantially free of monomeric phthalic acid esters and synthetic oils is described herein. Also provided are methods for making and using the enteric-coated oral dosage form. The disclosed pharmaceutical compositions comprise an enteric coating which includes at least one plasticizer, at least one film-forming agent and optionally at least one anti-sticking agent.

Abstract: In an arrangement and method for active vibration compensation of an x-ray radiator, a counter-vibration generation unit is arranged within the x-ray radiator to reduce a vibration arising during operation of the x-ray radiator. The counter-vibration generating unit is engaged in an active connection with the x-ray radiator and generates a counter-vibration that is phase-shifted by 180 degrees relative to the operational vibration. Operational vibrations generated by the x-ray radiator can be directly reduced at the point of origin by the application of active counter-vibrations in the immediate proximity of the vibration generator. Additional vibration transmission to other system parts (for example a C-arm) is thereby reduced or prevented.

Abstract: Media content playback includes providing a plurality of media contents; providing for each of the media contents information identifying the respective media content; receiving from a user selection instructions that effect selecting or deselecting of a specific media content; providing context data based on measurements of at least one of absolute time, absolute position and of at least one physical quantity at or in the vicinity of the location where the selected media content is to be reproduced; providing or adapting a user profile that assigns for each specific media content user instructions to the context data provided at the time of receipt of the respective instruction; selecting according to the user profile one of the media contents dependent on the context data at the time of selection; and reproducing the selected media content.

Abstract: The sound reproduction of a multichannel sound reproduction system with a plurality of speakers which is connected to the output of an FM stereo receiver is controlled by a control signal derived from the reception quality. Preferably, the control signal from the FM stereo receiver for controlling the stereo and mono components is also employed to control the multichannel sound reproduction system. For example, stereo, pseudo-stereo or mono reproduction are provided in the multichannel sound reproduction system in response to the stereo component within the output signal.

Abstract: The present invention relates to pharmaceutical compositions comprising granules containing at least one recombinantly produced purified microbial lipase, the use of said pharmaceutical compositions for the manufacture of a medicament for the prevention or treatment of certain diseases or disorders like pancreatic endocrine insufficiency, and a process for the manufacture of said pharmaceutical compositions.

Abstract: A method for analyzing the identity, protein and/or peptide pattern and also the stability of samples containing physiologically acceptable enzyme mixtures with lipolytic, proteolytic and amylolytic activity, particularly mixtures of digestive enzymes such as pancreatin, for use in manufacturing medicinal products comprising such enzyme mixtures, e.g. precipitated pancreatin or pancreatin mini-microspheres.